January 3, 2025 - 19:27

Catherine Chavers, the longtime chair of the Bois Forte Band of Chippewa, has announced her resignation, citing mental health concerns as the primary reason for her decision. Chavers, who was beginning her third term in office, has been a prominent figure in the community, advocating for various initiatives and representing the interests of the tribe. Her departure marks a significant change in leadership for the Bois Forte Band, which has been navigating various challenges and opportunities in recent years.
In her statement, Chavers expressed gratitude for the support she received during her tenure and emphasized the importance of mental health awareness. The community has been encouraged to rally together during this transition period as the band seeks to appoint a new leader. Chavers' commitment to her role and the tribe's well-being has left a lasting impact, and her resignation is felt deeply by many within the community. The Bois Forte Band now faces the task of finding a successor who can continue the work and vision that Chavers championed.
December 12, 2025 - 02:10
Senate Republicans Halt Efforts to Extend Health Insurance SubsidiesOn Thursday, Senate Republicans successfully blocked a motion aimed at advancing a Democratic proposal to prolong enhanced health insurance premium subsidies, which are set to expire at the end of...
December 11, 2025 - 08:03
WHO's New Pandemic Agreement: A Step Towards Equity in Global HealthOn May 20, 2025, the World Health Assembly reached a significant milestone by unanimously adopting the World Health Organization (WHO) Pandemic Agreement, an international treaty aimed at enhancing...
December 10, 2025 - 23:09
UAMS Expands Community Health Worker Training Initiative in ArkansasLITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) Institute for Community Health Innovation is set to enhance the community health worker (CHW) workforce in Arkansas with the...
December 10, 2025 - 04:47
FDA Initiates Safety Review of RSV Medications for Infants Amid Immunization ConcernsThe Food and Drug Administration (FDA) has announced a safety review of two medications designed to combat respiratory syncytial virus (RSV) in infants. This decision comes as scrutiny increases...